ASH 2020 – Focused on CLL, MCL, and WM

Doctor with cancer patient

Zanubrutinib Is Well Tolerated, Associated with High Clinical Activity in R/R Waldenstrom Macroglobulinemia

Treatment with zanubrutinib was well tolerated and associated with high clinical activity in patients with relapsed/refractory (R/R) Waldenstrom macroglobulinemia (WM), according to a phase...

Novel DNA Vaccine Reduces Tumor Clones, Favorably Alters Immune Microenvironment in Patients with Untreated...

A novel idiotype (scFv-CCL20) DNA vaccine was associated with favorable perturbation of the immune microenvironment in patients with untreated smoldering Waldenstrom macroglobulinemia (WM), according...

First-Line Ibrutinib Plus Venetoclax Improves Rates of uMRD in Patients With CLL and SLL

A first-line regimen consisting of once-daily ibrutinib plus venetoclax was associated with high rates of undetectable minimal residual disease (uMRD) in peripheral blood and...
Cropped shot of a contemplative senior man standing alone in his home and enjoying a cup of coffee

Adding Rituximab to Ixazomib as Post-AHCT Maintenance in MCL Increases Risk of Myelosuppression

A study has found that the addition of rituximab to ixazomib, when used as maintenance therapy following autologous hematopoietic cell transplant (AHCT), is associated...

Early Initiation of Zanubrutinib in CLL Improves Response, Durable Survival

Early initiation of Bruton’s tyrosine kinase inhibitor zanubrutinib in patients with chronic lymphocytic leukemia (CLL), especially in treatment-naïve patients and those who have received...

Recent Hematology and Oncology Headlines

Hypofractionated, Breast Cancer Incidence Differs Among Black and White Males

Researchers Assess Trends in Myeloma Incidence and Mortality

A research team from the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention assessed recent trends in incidence...

COVID-19 Update: President-elect Biden Outlines $1.9 Trillion Coronavirus Relief Plan; Fauci Says 100 Million...

On Thursday, January 14, 2021, here are the latest COVID-19 numbers around the world, according to statistics aggregator, Worldometer.  World Cases: Over 93.8 million. ...
eligibility, ORLM, Pegilodecakin with Pembrolizumab or Nivolumab Effectively Treats Tumors

New Guidelines for Lung Cancer Improve Eligibility Among Minorities, But Don’t Close Racial Gap

An analysis of the latest US Preventive Services Task Force (USPSTF) lung cancer screening guideline for screening eligibility found that while improvements were made...

Researchers Develop Tool that Predicts Chemotherapy Toxicity in Older Adults

Researchers developed a precision medicine tool that predicts grade 3-5 chemotherapy toxicity in older adults with early-stage breast cancer. The study appeared in the...